Clinical advantages of nebivolol in the treatment of hypertension
- VernacularTitle:奈必洛尔用于高血压的临床治疗优势
- Author:
Ping LI
1
;
Chang LIU
1
;
Xiaoce GU
2
;
Lixia SHEN
3
Author Information
1. Dept. of Clinical Pharmacy，Qingdao Women and Children’s Hospital，Shandong Qingdao 266034，China
2. Health Team，Unit 92038 of the People’s Liberation Army，Shandong Qingdao 266200，China
3. Dept. of Pharmacy，Hospital 971 of the Navy of Chinese People’s Liberation Army，Shandong Qingdao 266071，China
- Publication Type:Journal Article
- Keywords:
nebivolol;
β-blocker;
anti-hypertensive;
clinical advantages
- From:
China Pharmacy
2023;34(16):2044-2048
- CountryChina
- Language:Chinese
-
Abstract:
β-blocker is one of the commonly used anti-hypertensive drugs， and there are obvious differences in the selection of this class of drugs. Nebivolol is a third-generation β-blocker with a unique mechanism of action. This article summarizes the clinical application of nebivolol in anti-hypertensive treatment in recent years， and it is found that compared with other β-blockers， nebivolol has certain clinical treatment advantages. In addition to having a significant antihypertensive effect， it also has little impact on sexual function and heart rate of patients， and does not affect the blood glucose and lipid metabolism， so the drug is more suitable for some special groups of patients， including sexually active male hypertensive patients， hypertensive patients with complications such as type 2 diabetes mellitus and metabolic syndrome.
